drugset / Trial / NCT01091818
Dexmedetomidine Versus Midazolam for Intensive Care Sedation of Children
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
Dexmedetomidine will be tested against midazolam in a prospective, randomized, double-blind study of intensive care children, age 2-17 years. The investigators' primary hypothesis is that time from end of medication to extubation will be shorter with dexmedetomidine sedation.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | — | — |
| Comparator | Midazolam | Small molecule | — | — |
Indications
No indication recorded.